Vuno Inc
KOSDAQ:338220
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ark Restaurants Corp
NASDAQ:ARKR
|
US |
Vuno Inc
Research & Development
Vuno Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Vuno Inc
KOSDAQ:338220
|
Research & Development
-₩5.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Research & Development
-₩31.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-12%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Research & Development
-₩16.7B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Research & Development
-₩1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Research & Development
-₩2.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Research & Development
-₩4.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vuno Inc
Glance View
VUNO Inc. engages in the development of healthcare algorithms and software solutions. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-02-26. In addition, the Company sells an embolic material product, Nexpear. The firm sells its products in domestic and overseas markets such as Japan, Europe, and the United States.
See Also
What is Vuno Inc's Research & Development?
Research & Development
-5.3B
KRW
Based on the financial report for Dec 31, 2024, Vuno Inc's Research & Development amounts to -5.3B KRW.
What is Vuno Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-26%
Over the last year, the Research & Development growth was -13%. The average annual Research & Development growth rates for Vuno Inc have been -1% over the past three years , -26% over the past five years .
